Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
6.20
+0.21 (3.51%)
At close: Oct 13, 2026, 4:00 PM EDT
6.17
-0.03 (-0.48%)
After-hours: Oct 13, 2026, 4:35 PM EDT
Embecta Market Cap
Embecta has a market cap or net worth of $351.29 million as of October 13, 2026. It is the 17,505th most valuable company in the world and the 3,088th biggest in the United States. Its market cap has decreased by 55.11% in one year.
Market Cap
351.29M
Enterprise Value
1.64B
1-Year Change
-55.11%
Global Rank
Country Rank
#3,088 United States
Category
ChartMarket Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $351.29M, a decrease of -86.87%. That is a compound annual growth rate of -35.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 351.29M | -50.06% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kestra Medical Technologies | 1.61B |
| STAAR Surgical Company | 1.09B |
| AngioDynamics | 484.47M |
| Sanara MedTech | 322.22M |
| OraSure Technologies | 268.98M |
| Utah Medical Products | 237.32M |
| Anbio Biotechnology | 204.53M |
| Pro-Dex | 200.18M |